Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Report 2021
1 Glucagon-like Peptide-2 (GLP-2) Agonist Market Overview
- 1.1 Glucagon-like Peptide-2 (GLP-2) Agonist Product Scope
- 1.2 Glucagon-like Peptide-2 (GLP-2) Agonist Segment by Type
- 1.2.1 Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales by Type (2016 & 2021 & 2027)
- 1.2.2 Gattex
- 1.2.3 Revestive
- 1.3 Glucagon-like Peptide-2 (GLP-2) Agonist Segment by Application
- 1.3.1 Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Comparison by Application (2016 & 2021 & 2027)
- 1.3.2 Hospital
- 1.3.3 Pharmacy
- 1.3.4 Other
- 1.4 Glucagon-like Peptide-2 (GLP-2) Agonist Market Estimates and Forecasts (2016-2027)
- 1.4.1 Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Size in Value Growth Rate (2016-2027)
- 1.4.2 Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Size in Volume Growth Rate (2016-2027)
- 1.4.3 Global Glucagon-like Peptide-2 (GLP-2) Agonist Price Trends (2016-2027)
2 Glucagon-like Peptide-2 (GLP-2) Agonist Estimates and Forecasts by Region
- 2.1 Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Size by Region: 2016 VS 2021 VS 2027
- 2.2 Global Glucagon-like Peptide-2 (GLP-2) Agonist Retrospective Market Scenario by Region (2016-2021)
- 2.2.1 Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Region (2016-2021)
- 2.2.2 Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Market Share by Region (2016-2021)
- 2.3 Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Estimates and Forecasts by Region (2022-2027)
- 2.3.1 Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Estimates and Forecasts by Region (2022-2027)
- 2.3.2 Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Forecast by Region (2022-2027)
- 2.4 Geographic Market Analysis: Market Facts & Figures
- 2.4.1 North America Glucagon-like Peptide-2 (GLP-2) Agonist Estimates and Projections (2016-2027)
- 2.4.2 Europe Glucagon-like Peptide-2 (GLP-2) Agonist Estimates and Projections (2016-2027)
- 2.4.3 China Glucagon-like Peptide-2 (GLP-2) Agonist Estimates and Projections (2016-2027)
- 2.4.4 Japan Glucagon-like Peptide-2 (GLP-2) Agonist Estimates and Projections (2016-2027)
- 2.4.5 Southeast Asia Glucagon-like Peptide-2 (GLP-2) Agonist Estimates and Projections (2016-2027)
- 2.4.6 India Glucagon-like Peptide-2 (GLP-2) Agonist Estimates and Projections (2016-2027)
3 Global Glucagon-like Peptide-2 (GLP-2) Agonist Competition Landscape by Players
- 3.1 Global Top Glucagon-like Peptide-2 (GLP-2) Agonist Players by Sales (2016-2021)
- 3.2 Global Top Glucagon-like Peptide-2 (GLP-2) Agonist Players by Revenue (2016-2021)
- 3.3 Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Glucagon-like Peptide-2 (GLP-2) Agonist as of 2020)
- 3.4 Global Glucagon-like Peptide-2 (GLP-2) Agonist Average Price by Company (2016-2021)
- 3.5 Manufacturers Glucagon-like Peptide-2 (GLP-2) Agonist Manufacturing Sites, Area Served, Product Type
- 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Size by Type
- 4.1 Global Glucagon-like Peptide-2 (GLP-2) Agonist Historic Market Review by Type (2016-2021)
- 4.1.1 Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Type (2016-2021)
- 4.1.2 Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Market Share by Type (2016-2021)
- 4.1.3 Global Glucagon-like Peptide-2 (GLP-2) Agonist Price by Type (2016-2021)
- 4.2 Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Estimates and Forecasts by Type (2022-2027)
- 4.2.1 Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Forecast by Type (2022-2027)
- 4.2.2 Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Forecast by Type (2022-2027)
- 4.2.3 Global Glucagon-like Peptide-2 (GLP-2) Agonist Price Forecast by Type (2022-2027)
5 Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Size by Application
- 5.1 Global Glucagon-like Peptide-2 (GLP-2) Agonist Historic Market Review by Application (2016-2021)
- 5.1.1 Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Application (2016-2021)
- 5.1.2 Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Market Share by Application (2016-2021)
- 5.1.3 Global Glucagon-like Peptide-2 (GLP-2) Agonist Price by Application (2016-2021)
- 5.2 Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Estimates and Forecasts by Application (2022-2027)
- 5.2.1 Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Forecast by Application (2022-2027)
- 5.2.2 Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Forecast by Application (2022-2027)
- 5.2.3 Global Glucagon-like Peptide-2 (GLP-2) Agonist Price Forecast by Application (2022-2027)
6 North America Glucagon-like Peptide-2 (GLP-2) Agonist Market Facts & Figures
- 6.1 North America Glucagon-like Peptide-2 (GLP-2) Agonist Sales by Company
- 6.1.1 North America Glucagon-like Peptide-2 (GLP-2) Agonist Sales by Company (2016-2021)
- 6.1.2 North America Glucagon-like Peptide-2 (GLP-2) Agonist Revenue by Company (2016-2021)
- 6.2 North America Glucagon-like Peptide-2 (GLP-2) Agonist Sales Breakdown by Type
- 6.2.1 North America Glucagon-like Peptide-2 (GLP-2) Agonist Sales Breakdown by Type (2016-2021)
- 6.2.2 North America Glucagon-like Peptide-2 (GLP-2) Agonist Sales Breakdown by Type (2022-2027)
- 6.3 North America Glucagon-like Peptide-2 (GLP-2) Agonist Sales Breakdown by Application
- 6.3.1 North America Glucagon-like Peptide-2 (GLP-2) Agonist Sales Breakdown by Application (2016-2021)
- 6.3.2 North America Glucagon-like Peptide-2 (GLP-2) Agonist Sales Breakdown by Application (2022-2027)
7 Europe Glucagon-like Peptide-2 (GLP-2) Agonist Market Facts & Figures
- 7.1 Europe Glucagon-like Peptide-2 (GLP-2) Agonist Sales by Company
- 7.1.1 Europe Glucagon-like Peptide-2 (GLP-2) Agonist Sales by Company (2016-2021)
- 7.1.2 Europe Glucagon-like Peptide-2 (GLP-2) Agonist Revenue by Company (2016-2021)
- 7.2 Europe Glucagon-like Peptide-2 (GLP-2) Agonist Sales Breakdown by Type
- 7.2.1 Europe Glucagon-like Peptide-2 (GLP-2) Agonist Sales Breakdown by Type (2016-2021)
- 7.2.2 Europe Glucagon-like Peptide-2 (GLP-2) Agonist Sales Breakdown by Type (2022-2027)
- 7.3 Europe Glucagon-like Peptide-2 (GLP-2) Agonist Sales Breakdown by Application
- 7.3.1 Europe 133 Sales Breakdown by Application (2016-2021)
- 7.3.2 Europe 133 Sales Breakdown by Application (2022-2027)
8 China Glucagon-like Peptide-2 (GLP-2) Agonist Market Facts & Figures
- 8.1 China Glucagon-like Peptide-2 (GLP-2) Agonist Sales by Company
- 8.1.1 China Glucagon-like Peptide-2 (GLP-2) Agonist Sales by Company (2016-2021)
- 8.1.2 China Glucagon-like Peptide-2 (GLP-2) Agonist Revenue by Company (2016-2021)
- 8.2 China Glucagon-like Peptide-2 (GLP-2) Agonist Sales Breakdown by Type
- 8.2.1 China Glucagon-like Peptide-2 (GLP-2) Agonist Sales Breakdown by Type (2016-2021)
- 8.2.2 China Glucagon-like Peptide-2 (GLP-2) Agonist Sales Breakdown by Type (2022-2027)
- 8.3 China Glucagon-like Peptide-2 (GLP-2) Agonist Sales Breakdown by Application
- 8.3.1 China 245 Sales Breakdown by Application (2016-2021)
- 8.3.2 China 245 Sales Breakdown by Application (2022-2027)
9 Japan Glucagon-like Peptide-2 (GLP-2) Agonist Market Facts & Figures
- 9.1 Japan Glucagon-like Peptide-2 (GLP-2) Agonist Sales by Company
- 9.1.1 Japan Glucagon-like Peptide-2 (GLP-2) Agonist Sales by Company (2016-2021)
- 9.1.2 Japan Glucagon-like Peptide-2 (GLP-2) Agonist Revenue by Company (2016-2021)
- 9.2 Japan Glucagon-like Peptide-2 (GLP-2) Agonist Sales Breakdown by Type
- 9.2.1 Japan Glucagon-like Peptide-2 (GLP-2) Agonist Sales Breakdown by Type (2016-2021)
- 9.2.2 Japan Glucagon-like Peptide-2 (GLP-2) Agonist Sales Breakdown by Type (2022-2027)
- 9.3 Japan Glucagon-like Peptide-2 (GLP-2) Agonist Sales Breakdown by Application
- 9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
- 9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Glucagon-like Peptide-2 (GLP-2) Agonist Market Facts & Figures
- 10.1 Southeast Asia Glucagon-like Peptide-2 (GLP-2) Agonist Sales by Company
- 10.1.1 Southeast Asia Glucagon-like Peptide-2 (GLP-2) Agonist Sales by Company (2016-2021)
- 10.1.2 Southeast Asia Glucagon-like Peptide-2 (GLP-2) Agonist Revenue by Company (2016-2021)
- 10.2 Southeast Asia Glucagon-like Peptide-2 (GLP-2) Agonist Sales Breakdown by Type
- 10.2.1 Southeast Asia Glucagon-like Peptide-2 (GLP-2) Agonist Sales Breakdown by Type (2016-2021)
- 10.2.2 Southeast Asia Glucagon-like Peptide-2 (GLP-2) Agonist Sales Breakdown by Type (2022-2027)
- 10.3 Southeast Asia Glucagon-like Peptide-2 (GLP-2) Agonist Sales Breakdown by Application
- 10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
- 10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)
11 India Glucagon-like Peptide-2 (GLP-2) Agonist Market Facts & Figures
- 11.1 India Glucagon-like Peptide-2 (GLP-2) Agonist Sales by Company
- 11.1.1 India Glucagon-like Peptide-2 (GLP-2) Agonist Sales by Company (2016-2021)
- 11.1.2 India Glucagon-like Peptide-2 (GLP-2) Agonist Revenue by Company (2016-2021)
- 11.2 India Glucagon-like Peptide-2 (GLP-2) Agonist Sales Breakdown by Type
- 11.2.1 India Glucagon-like Peptide-2 (GLP-2) Agonist Sales Breakdown by Type (2016-2021)
- 11.2.2 India Glucagon-like Peptide-2 (GLP-2) Agonist Sales Breakdown by Type (2022-2027)
- 11.3 India Glucagon-like Peptide-2 (GLP-2) Agonist Sales Breakdown by Application
- 11.3.1 India Glucagon-like Peptide-2 (GLP-2) Agonist Sales Breakdown by Application (2016-2021)
- 11.3.2 India Glucagon-like Peptide-2 (GLP-2) Agonist Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Glucagon-like Peptide-2 (GLP-2) Agonist Business
- 12.1 Takeda Pharmaceuticals
- 12.1.1 Takeda Pharmaceuticals Corporation Information
- 12.1.2 Takeda Pharmaceuticals Business Overview
- 12.1.3 Takeda Pharmaceuticals Glucagon-like Peptide-2 (GLP-2) Agonist Sales, Revenue and Gross Margin (2016-2021)
- 12.1.4 Takeda Pharmaceuticals Glucagon-like Peptide-2 (GLP-2) Agonist Products Offered
- 12.1.5 Takeda Pharmaceuticals Recent Development
...
13 Glucagon-like Peptide-2 (GLP-2) Agonist Manufacturing Cost Analysis
- 13.1 Glucagon-like Peptide-2 (GLP-2) Agonist Key Raw Materials Analysis
- 13.1.1 Key Raw Materials
- 13.1.2 Key Raw Materials Price Trend
- 13.1.3 Key Suppliers of Raw Materials
- 13.2 Proportion of Manufacturing Cost Structure
- 13.3 Manufacturing Process Analysis of Glucagon-like Peptide-2 (GLP-2) Agonist
- 13.4 Glucagon-like Peptide-2 (GLP-2) Agonist Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
- 14.1 Marketing Channel
- 14.2 Glucagon-like Peptide-2 (GLP-2) Agonist Distributors List
- 14.3 Glucagon-like Peptide-2 (GLP-2) Agonist Customers
15 Market Dynamics
- 15.1 Glucagon-like Peptide-2 (GLP-2) Agonist Market Trends
- 15.2 Glucagon-like Peptide-2 (GLP-2) Agonist Drivers
- 15.3 Glucagon-like Peptide-2 (GLP-2) Agonist Market Challenges
- 15.4 Glucagon-like Peptide-2 (GLP-2) Agonist Market Restraints
16 Research Findings and Conclusion
17 Appendix
- 17.1 Research Methodology
- 17.1.1 Methodology/Research Approach
- 17.1.2 Data Source
- 17.2 Author List
The global Glucagon-like Peptide-2 (GLP-2) Agonist market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Glucagon-like Peptide-2 (GLP-2) Agonist market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Gattex
Revestive
Segment by Application
Hospital
Pharmacy
Other
The Glucagon-like Peptide-2 (GLP-2) Agonist market is analysed and market size information is provided by regions (countries). Segment by Application, the Glucagon-like Peptide-2 (GLP-2) Agonist market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Takeda Pharmaceuticals